FDA panel recommends Moderna’s mRNA flu shot for older adults (opens original article in a new tab)

An FDA advisory panel recommended Moderna's mRNA flu shot for older adults, which could offer a more effective and faster-developing alternative to traditional flu vaccines, but final approval and recommendations are still pending.

• FDA advisory panel recommended Moderna's mRNA flu shot for older adults
• The vaccine is 27% more effective than standard flu shots in late-stage trials
• FDA approval and CDC recommendation are still needed for availability this fall